RTROME Therapeutics Team
ROME Therapeutics
Last updated: February 23, 2026
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Andreessen Horowitz, $50M Series B in 2021, $70M valuation
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Andreessen Horowitz, $50M Series B in 2021, $70M valuation
- Series B • Andreessen Horowitz, $50M Series B in 2021, $70M valuation
Founder Intelligence Brief: ROME Therapeutics Team
This profile is built to help readers move from a founder name to decision-ready context. ROME Therapeutics Team is mapped to ROME Therapeutics in the Biotech category, with current stage context as Series B. The primary operating market is Boston, Massachusetts, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $50.00M, with the latest mapped round as Series B (Andreessen Horowitz, $50M Series B in 2021, $70M valuation). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Biotech startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Biotech industry routes and Series B stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Series B funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Biotech.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About ROME Therapeutics Team
Common questions people ask about this profile.
Who is ROME Therapeutics Team?
ROME Therapeutics Team is the founder profile listed on 100Xfounder for ROME Therapeutics, tracked for market signals, company intelligence, and operator-level context.
What does ROME Therapeutics do?
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Where is ROME Therapeutics based?
ROME Therapeutics is listed as operating from Boston, Massachusetts, USA.
What is the current funding stage of ROME Therapeutics?
ROME Therapeutics is currently categorized at Series B on 100Xfounder. Funding signal: Andreessen Horowitz, $50M Series B in 2021, $70M valuation
What is the latest funding round for ROME Therapeutics?
The latest tracked round for ROME Therapeutics is Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation. Total tracked rounds: 1.
Is ROME Therapeutics hiring right now?
Current hiring signal for ROME Therapeutics: Open Roles.
Is ROME Therapeutics Team's profile verified?
Yes. ROME Therapeutics Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with ROME Therapeutics Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for rometx.com.
What technologies are associated with ROME Therapeutics?
ROME Therapeutics is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.